[HTML][HTML] Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation
EAS Koster, PA von dem Borne, P Van Balen… - Frontiers in …, 2024 - frontiersin.org
Introduction Unmodified donor lymphocyte infusions (DLI) after allogeneic stem cell
transplantation (alloSCT) can boost the beneficial Graft-versus-Leukemia (GvL) effect but …
transplantation (alloSCT) can boost the beneficial Graft-versus-Leukemia (GvL) effect but …
Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation
EA Koster, PA von dem Borne, P Van Balen… - Frontiers in … - frontiersin.org
Unmodified donor lymphocyte infusions (DLI) after allogeneic stem cell transplantation
(alloSCT) can boost the beneficial Graft-versus-Leukemia (GvL) effect but may also induce …
(alloSCT) can boost the beneficial Graft-versus-Leukemia (GvL) effect but may also induce …